(2-methyl-4-(methylamino)pyrazolo[1,5-a][1,3,5]triazin-8-yl)(phenyl)methanone

ID: ALA454084

PubChem CID: 12023163

Max Phase: Preclinical

Molecular Formula: C14H13N5O

Molecular Weight: 267.29

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1nc(C)nc2c(C(=O)c3ccccc3)cnn12

Standard InChI:  InChI=1S/C14H13N5O/c1-9-17-13-11(8-16-19(13)14(15-2)18-9)12(20)10-6-4-3-5-7-10/h3-8H,1-2H3,(H,15,17,18)

Standard InChI Key:  VBOCKEFYRKUQPD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    2.6471  -11.9349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6471  -12.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9327  -13.1724    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9327  -11.5224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2182  -11.9349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2182  -12.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4336  -13.0149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0513  -12.3474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4336  -11.6800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9327  -10.6974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6471  -10.2849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3616  -13.1724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1786  -13.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7307  -14.4126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6283  -13.9710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8833  -14.7556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6902  -14.9272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2423  -14.3141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9873  -13.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1804  -13.3579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  2  0
  4 10  1  0
  5  6  1  0
 10 11  1  0
  2 12  1  0
  2  3  2  0
  3  6  1  0
  1  2  1  0
 13 14  2  0
 13 15  1  0
  7 13  1  0
  5  4  1  0
 15 16  2  0
  6  7  2  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
  8  9  2  0
 18 19  1  0
  9  5  1  0
 19 20  2  0
 20 15  1  0
M  END

Associated Targets(non-human)

PDE2A Phosphodiesterase 2A (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 267.29Molecular Weight (Monoisotopic): 267.1120AlogP: 1.71#Rotatable Bonds: 3
Polar Surface Area: 72.18Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.49CX LogP: 2.17CX LogD: 2.17
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.73Np Likeness Score: -1.43

References

1. Raboisson P, Schultz D, Muller C, Reimund JM, Pinna G, Mathieu R, Bernard P, Do QT, Desjarlais RL, Justiano H, Lugnier C, Bourguignon JJ..  (2008)  Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.,  43  (4): [PMID:17640774] [10.1016/j.ejmech.2007.05.016]

Source